Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon

Japanese Journal of Cancer Research

Volumn 88, Issue 9, 1997, Pages 815-820

  Morishita, Yukio ^a   Yoshimi, Naoki ^a   Kawabata, Kunihiro ^a   Matsunaga, Kengo ^a   Sugie, Shigeyuki ^a   Tanaka, Takuji ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Aberrant crypt foci; Azoxymethane; Chemoprevention; Colon; Regression

Indexed keywords

AZOXYMETHANE; CARCINOGEN; CHLOROGENIC ACID; FURANONE DERIVATIVE; PIROXICAM; THIOSULFINIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; CRYPT CELL; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT;

EID: 0030667746     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00456.x     Document Type: Article

References (25)

1. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res., 45, 1-8 (1985).
2. Wattenberg, L. W. Inhibitors of chemical carcinogens. Adv. Cancer Res., 26, 197-226 (1978).
3. Mori, H., Tanaka, T., Sugie, S. and Yoshimi, N. Chemopreventive effects of plant derived phenolic, organosulfur and other compounds on carcinogenesis in digestive organs. Environ. Mutagen Res. Commun., 17, 127-133 (1995).
4. Kingsnorth, A. N., King, W. W. K., Diekema, K. A., McCann, P. P., Ross, J. S. and Malt, R. A. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res., 43, 2545-2549 (1983).
5. Reddy, B. S., Maruyama, H. and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346 (1987).
6. McLellan, E. A. and Bird, R. P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48, 6187-6192 (1988).
7. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71 (1995).
8. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Jurcisek, J. A. and Stellato, T. A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567 (1991).
9. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151 (1987).
10. Kawamori, T., Tanaka, T., Hara, A., Yamahara, J. and Mori, H. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res., 55, 1277-1282 (1995).
11. Pereira, M. A., Barnes, L. H., Steele, V. E., Kelloff, G. V. and Lubet, R. A. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats. Carcinogenesis, 17, 373-376 (1996).
12. Kawamori, T., Tanaka, T., Suzui, M., Okamoto, K., Tamai, Y., Torihara, M., Yamahara, J. and Mori, H. Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, in rats. Carcinogenesis, 16, 795-800 (1995).
13. Kawamori, T., Tanaka, T., Ohnishi, M., Hirose, Y., Nakamura, Y., Satoh, K., Hara, A. and Mori, H. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats. Cancer Res., 55, 4053-4058 (1995).
14. Mori, H., Tanaka, T., Shima, H., Kuniyasu, T. and Takahashi, M. Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett., 30, 49-54 (1986).
15. Mori, H., Yoshimi, N., Tanaka, T. and Hirose, Y. Experimental colorectal carcinogenesis: role of cell proliferation. In "Recent Advances in Gastroenterological Carcinogenesis I," ed. E. Tahara, K. Sugimachi and T. Oohara, pp. 249-253 (1996). Monduzzi Editore, Bologna.
16. Kawamori, T., Tanaka, T., Hirose, Y., Satoh, K., Hara, A., Torihara, M., Tamai, Y., Yamahara, J. and Mori, H. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats. Cancer Lett., 92, 159-165 (1995).
17. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V. and Steele, V. E. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15, 1049-1054 (1994).
18. Kasai, H., Chung, M.-H., Yamamoto, F., Ohtsuka, E., Laval, J., Grollman, A. P. and Nishimura, S. Formation, inhibition of formation, and repair of oxidative 8-hydroxyguanine DNA damage. In "Antimutagenesis and Anticarcinogenesis Mechanisms III," ed. G. Bronzetti, H. Hayatsu, S. DeFlora, M.D. Waters and D.M. Shankel, pp. 257-262 (1993). Plenum Press, New York & London.
19. Mori, H., Yoshimi, N., Sugie, S., Tanaka, T., Morishita, Y., Jinlong, G., Tamai, Y., Torihara, M., Yamahara, J. Inhibitory effect of 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, a novel synthesized retinoid, on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett., 66, 93-98 (1992).
20. Pretlow, T. P., O'Riordan, M. A., Somich, G. A., Amini, S. B. and Pretlow, T. G. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512 (1992).
21. Magnuson, B. A., Carr, I. and Bird, R. P. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res., 53, 4499-4504 (1993).
22. Bird, R. P. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett., 88, 202-209 (1995).
23. Shiff, S. J., Koutsos, M. I., Qiao, L. and Rigas, B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188 (1996).
24. Samaha, H. S., Kelloff, G. J., Steele, V., Rao, C. V. and Reddy, B. S. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301-1305 (1997).
25. Giardello, F. M., Hamilton, S. R., Krush, A. J., Piantodosi, S., Hylind, L. M., Cleano, P., Booker, S. V., Robinson, R. C. and Offerhaus, G. J. A. Treatment of colonic rectal adenomas with sulindac in familial adenomatosis polyposis. N. Engl. J. Med., 328, 1313-1316 (1993).